# Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors

> clinical trial · VERIFIED · 2026-08-07

Status: RECRUITING · Sponsor: ZSky Biotech Inc · Condition: Advanced Solid Tumor

- Company: ZSky Biotech Inc
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07752953

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.